Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Related Citations for PubMed (Select 23837113)

1.

Role of imaging in the detection of reversible cardiomyopathy.

Park JH, Kwon DH, Starling RC, Marwick TH.

J Cardiovasc Ultrasound. 2013 Jun;21(2):45-55. doi: 10.4250/jcu.2013.21.2.45. Epub 2013 Jun 26.

3.

Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.

Westenberg JJ, Braun J, Van de Veire NR, Klautz RJ, Versteegh MI, Roes SD, van der Geest RJ, de Roos A, van der Wall EE, Reiber JH, Bax JJ, Dion RA.

J Thorac Cardiovasc Surg. 2008 Jun;135(6):1247-52; discussion 1252-3. doi: 10.1016/j.jtcvs.2007.10.021.

PMID:
18544363
4.

Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging.

Mouquet F, Lions C, de Groote P, Bouabdallaoui N, Willoteaux S, Dagorn J, Deruelle P, Lamblin N, Bauters C, Beregi JP.

Eur Radiol. 2008 Dec;18(12):2765-9. doi: 10.1007/s00330-008-1067-x. Epub 2008 Jul 19.

PMID:
18642002
5.

[Prognostic relevance of left ventricular diastolic function parameters in dilated cardiomyopathy].

Schannwell CM, Schoebel FC, Marx R, Plehn G, Leschke M, Strauer BE.

Z Kardiol. 2001 Apr;90(4):269-79. German.

PMID:
11381575
6.

Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.

Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB.

Eur Heart J. 2012 Mar;33(5):640-8. doi: 10.1093/eurheartj/ehr391. Epub 2011 Nov 1.

7.

Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.

Leonardi B, Margossian R, Colan SD, Powell AJ.

JACC Cardiovasc Imaging. 2008 Sep;1(5):572-8. doi: 10.1016/j.jcmg.2008.04.005.

8.

Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.

Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.

Am Heart J. 2000 Apr;139(4):596-608.

PMID:
10740140
9.

The value of 99mTc-MIBI myocardial perfusion imaging in differentiation of heart failure conditioned by global left ventricular systolic impairment.

Ragaisyte N, Kavoliūniene A, Vaicekavicius E, Navickas R, Kulakiene I, Vencloviene J, Laukaitiene J, Janenaite J, Janavicius A.

Medicina (Kaunas). 2009;45(4):262-8.

10.

Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy.

Moon J, Ko YG, Chung N, Ha JW, Kang SM, Choi EY, Rim SJ.

Can J Cardiol. 2009 May;25(5):e147-50.

11.

[Heart failure with preserved left ventricular function: clinical, echocardiographic, and clinical course features. Prognostic factors].

Bounhoure JP, Massabuau P, Galinier M, Jordan C, Laurent JP, Marco J.

Bull Acad Natl Med. 2002;186(6):1003-13; discussion 1013-4. French.

PMID:
12587339
12.

Diastolic heart failure.

Mandinov L, Eberli FR, Seiler C, Hess OM.

Cardiovasc Res. 2000 Mar;45(4):813-25. Review.

13.

[The role of cardiovascular magnetic resonance imaging in the diagnosis and prognosis of patients with heart failure].

Hombach V, Merkle N, Rasche V, Bernhardt P, Rottbauer W.

Herz. 2011 Mar;36(2):84-93. doi: 10.1007/s00059-010-3418-z. German.

PMID:
21424346
14.

Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy.

Onorati F, Rubino AS, Marturano D, Pasceri E, Santarpino G, Zinzi S, Mascaro G, Renzulli A.

J Thorac Cardiovasc Surg. 2009 Sep;138(3):654-62. doi: 10.1016/j.jtcvs.2009.01.020. Epub 2009 Apr 8.

PMID:
19698852
15.

Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.

D'Andrea A, Salerno G, Scarafile R, Riegler L, Gravino R, Castaldo F, Cocchia R, Limongelli G, Romano M, Calabrò P, Nigro G, Cuomo S, Bossone E, Caso P, Calabrò R.

Pacing Clin Electrophysiol. 2009 Aug;32(8):1017-29. doi: 10.1111/j.1540-8159.2009.02434.x.

PMID:
19659622
16.

Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.

Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheorghiade M, Kim RJ.

Circulation. 2003 Oct 21;108(16):1945-53. Epub 2003 Oct 13.

17.

[Contribution of echocardiography to the diagnosis of patients with chronic heart failure].

Pinamonti B.

Ital Heart J Suppl. 2000 Oct;1(10):1311-6. Review. Italian.

PMID:
11068713
18.

[Echocardiographic follow-up of patients with heart failure. Which parameters should be measured? How often?].

Di Lenarda A, Sabbadini G, Pinamonti B, Sinagra G.

Ital Heart J Suppl. 2000 Nov;1(11):1404-10. Review. Italian.

PMID:
11109188
19.
20.

Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach.

Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U.

J Cardiovasc Magn Reson. 2008 Nov 4;10:50. doi: 10.1186/1532-429X-10-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk